Xaira Therapeutics

Xaira Therapeutics on causal AI models and X-Cell for drug discovery

Latent Space interviews Bo Wang (Chief Discovery Officer) and Ci Chu (Chief AI Scientist) at Xaira Therapeutics about their X-Cell model and their strategy of generating proprietary data to train causal AI models for drug discovery. The discussion centers on why causal models require causal data and how Xaira is investing heavily in data generation as a foundation for model building. This is a substantive look at how a well-funded biotech is operationalizing AI-native drug discovery at scale.